Skip to main content
Signal8

Stehman-Breen Catherine

SEC insider (Form 3/4/5 filer). CIK 0001702233. Director at Dyne Therapeutics, Inc. (DYN) and 2 other issuers. 13 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in WALTHAM, MA.

Companies Stehman-Breen Catherine has filed insider reports for

  • Dyne Therapeutics, Inc. (DYN): Director
  • Tenaya Therapeutics, Inc. (TNYA): Director
  • Generation Bio Co. (GBIO): Director
Stehman-Breen Catherine profile photo

Stehman-Breen Catherine

CIK: 0001702233

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (46.2%)

Compensation grants

Other (G, F, J, C, D, …)7 (53.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Dyne Therapeutics, Inc. logo
DYN

Dyne Therapeutics, Inc.

Director
Tenaya Therapeutics, Inc. logo
TNYA

Tenaya Therapeutics, Inc.

Director
Generation Bio Co. logo
GBIO

Generation Bio Co.

Director

Discretionary Trading P&L

Holdings

Transaction History (13 total)

  • Dyne Therapeutics, Inc. logo
    DYN

    Dyne Therapeutics, Inc.

    Jun 5, 2026
    Award

    Stock option (right to buy)

    Direct
    35.2K shares-
  • Tenaya Therapeutics, Inc. logo
    TNYA

    Tenaya Therapeutics, Inc.

    May 28, 2026
    Award

    Stock Option (Right to buy)

    Direct
    120K shares-
  • Generation Bio Co. logo
    GBIO

    Generation Bio Co.

    Feb 9, 2026
    Tender Offer
    Direct
    4.8K shares-
  • Generation Bio Co. logo
    GBIO

    Generation Bio Co.

    Feb 9, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    1.5K shares-
  • Generation Bio Co. logo
    GBIO

    Generation Bio Co.

    Feb 9, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    1.9K shares-
  • Generation Bio Co. logo
    GBIO

    Generation Bio Co.

    Feb 9, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    2.5K shares-
  • Generation Bio Co. logo
    GBIO

    Generation Bio Co.

    Feb 9, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    6K shares-
  • Generation Bio Co. logo
    GBIO

    Generation Bio Co.

    Feb 9, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    3K shares-
  • Generation Bio Co. logo
    GBIO

    Generation Bio Co.

    Feb 9, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    5.2K shares-
  • Generation Bio Co. logo
    GBIO

    Generation Bio Co.

    Jun 4, 2025
    Award

    Stock Option (right to buy)

    Direct
    30K shares-

1-10 of 13